New pill shows promise for lung scarring disease in early trial
Disease control
Completed
This study tested an experimental oral drug called INS018_055 in 71 adults with idiopathic pulmonary fibrosis (IPF), a condition that causes lung scarring and breathing difficulty. The main goal was to check the drug's safety and tolerability over 12 weeks compared to a placebo. …
Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated May 01, 2026 16:00 UTC